You are here

masitinib

AB Science Announces Significant Survival Data for Masitinib in ALS

BioSpace

Tue, 07/20/21 - 11:02 am

clinical trials

Clinical studies for AB Science's all-purpose anti-inflammatory drug grind to a halt as company flags potential risk of heart disease

Endpoints

Tue, 06/1/21 - 11:00 am

Alzheimer's disease

A Drug for Dogs Does Not a Biotech Make Is AB Science Lesson

Bloomberg

Fri, 06/12/15 - 09:35 am

AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover

Bloomberg

Thu, 02/2/12 - 09:15 am

gastrointestinal cancer